GENEWEAVE BIOSCIENCES

GeneWEAVE Biosciences Inc., an in vitro diagnostics company, develops clinical microbiology with diagnostic solutions to aid healthcare providers in the treatment of drug-resistant bacteria. It offers Smarticles technology, which is a molecular diagnostics technology that detects multi drug-resistant organisms and assesses antibiotic susceptibility directly from clinical samples. The company was founded in 2007 and is based in Los Gatos, California. As of August 13, 2015, GeneWEAVE Biosciences Inc. operates as a subsidiary of Roche Molecular Systems Inc.

#SimilarOrganizations #People #More

GENEWEAVE BIOSCIENCES

Industry:
Biotechnology Health Care Medical

Founded:
2007-01-01

Address:
Los Gatos, California, United States

Country:
United States

Status:
Active

Contact:
607-379-0233


Similar Organizations

henry-ford-health-system-logo

Henry Ford Health System

Henry Ford Health System (HFHS) is one of the nationโ€™s leading comprehensive, integrated health systems.

polymer-technology-systems-inc-logo

Polymer Technology Systems, Inc

Polymer Technology Systems is a medical device company specializing in diagnostics solutions.

trek-diagnostic-systems-logo

TREK Diagnostic Systems

TREK Diagnostic Systems develops and offers microbiology products and solutions.

Current Employees Featured

not_available_image

Steve Tablak
Steve Tablak Chief Executive Officer @ GeneWeave Biosciences
Chief Executive Officer

More informations about "GeneWeave Biosciences"

GeneWEAVE - Crunchbase Company Profile & Funding

GeneWeave Biosciences is advancing clinical microbiology with diagnostic solutions that will enable hospitals and physicians around the world to prevent drug-resistant infections, improve โ€ฆSee details»

Roche acquires GeneWEAVE to strengthen offerings in โ€ฆ

Aug 13, 2015 GeneWEAVE, Inc., based in Los Gatos, Calif., is a privately-held in vitro diagnostics company that is advancing clinical microbiology with diagnostic solutions to aid โ€ฆSee details»

Roche to Acquire GeneWEAVE for Up-to $425M

Aug 13, 2015 Roche has agreed to pay GeneWEAVE shareholders $190 million upfront and up to $235 million in payments tied to achieving product-related โ€ฆSee details»

Roche Grabs Superbug Diagnostics Firm GeneWeave Biosciences โ€ฆ

Aug 13, 2015 Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, โ€ฆSee details»

Geneweave Biosciences

GeneWeave Biosciences is advancing clinical microbiology with diagnostic solutions that will enable hospitals and physicians around the world to prevent drug-resistant infections, improve โ€ฆSee details»

Roche Acquires GeneWEAVE to Enhance Microbiology Diagnostic ...

Swiss pharmaceutical giant Roche recently signed a definitive agreement to buy GeneWEAVE BioSciences, Inc. Based in Los Gatos, CA, USA, GeneWEAVE focuses on innovative, clinical โ€ฆSee details»

Roche bags antibiotics diagnostics tech in $425M GeneWeave โ€ฆ

Aug 13, 2015 The pharma giant has snagged GeneWeave Biosciences, which is based in Los Gatos, CA. GeneWeave developed what it calls Smarticles tech, which can analyze Gram โ€ฆSee details»

GeneWeave - VentureRadar

GeneWeave Biosciences, Inc., based in Los Gatos, Calif., is a privately-held in vitro diagnostics company that is advancing clinical microbiology with diagnostic solutions that will enable โ€ฆSee details»

GeneWeave Biosciences - PitchBook

GeneWeave Biosciences General Information Description. Developer of a platform for the detection of infectious disease. The company is developing a transformative diagnostic โ€ฆSee details»

GeneWeave BioSciences - VentureRadar

GeneWeave BioSciences VentureRadar profile. Find out more about GeneWeave BioSciences including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»

Roche acquires GeneWEAVE to strengthen offerings in โ€ฆ

Aug 13, 2015 Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has signed a definitive agreement to acquire GeneWEAVE BioSciences, Inc. (GeneWEAVE), a privately โ€ฆSee details»

Roche Acquires Microbial Dx Firm GeneWeave for up to $425M

Aug 13, 2015 NEW YORK(GenomeWeb) โ€“ Roche today announced it has signed a definitive agreement to acquire clinical diagnostics firm GeneWeave BioSciences for as much as $425 โ€ฆSee details»

Roche GeneWEAVE - rapidmicrobiology

Roche has signed a definitive agreement to acquire GeneWEAVE BioSciences, Inc., a privately held company focused on innovative, clinical microbiology diagnostics solutions based in Los โ€ฆSee details»

Geneweave Biosciences, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Geneweave Biosciences, Inc. of Los Gatos, CA. Get the latest business insights from Dun & Bradstreet.See details»

Geneweave Biosciences, Inc. - CAGE.report

Nov 23, 2013 Geneweave Biosciences, Inc. Trade Name ("Doing Business As ..."): DUNS Number: 029853399 Parent DUNS Number: Address, line 1: 983 University Ave Bldg B200 ...See details»

GeneWeave Biosciences - Products, Competitors, Financials, โ€ฆ

Roche Acquires GeneWEAVE for $190M Upfront, Up to $235M in Contingent Product-Related Milestones The Deal: Roche (OTC: RHHBY ) announced Thursday, that it has signed a โ€ฆSee details»

GeneWeave Biosciences, Inc. - Center For Technology Licensing

Sep 6, 2017 GeneWeave Biosciences, Inc. September 6, 2017. Home » Startups » GeneWeave Biosciences, Inc. Tweet Share. GeneWeave Biosciences, Inc., is a medical diagnostics โ€ฆSee details»

GENEWEAVE BIOSCIENCES Revenue, Growth & Competitor Profile

Determine whether Geneweave Biosciences grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how โ€ฆSee details»

GeneWeave Biosciences Attracts $12M Series A - VC News Daily

About GeneWeave Biosciences GeneWeave Biosciences has created a new and innovative platform for the surveillance and detection of infectious disease. Their proprietary โ€ฆSee details»

The Return of the Dire Wolf | TIME

2 days ago The dire wolf isnโ€™t the only animal that Colossal, which was founded in 2021 and currently employs 130 scientists, wants to bring back. Also on their de-extinction wish list is the โ€ฆSee details»

linkstock.net © 2022. All rights reserved